The antioxidant lipoic acid (LA) treats and prevents the animal model of multiple sclerosis (MS), experimental autoimmune encephalomyelitis (EAE). In an effort to understand the therapeutic potential of LA in MS, we sought to define the cellular mechanisms that mediate the effects of LA on human natural killer (NK) cells, which are important in innate immunity as the first line of defense against invading pathogens and tumor cells. We discovered that LA stimulates cAMP production in NK cells in a dose-dependent manner. Studies using pharmacological inhibitors and receptor transfection experiments indicate that LA stimulates cAMP production via activation of the EP2 and EP4 prostanoid receptors and adenylyl cyclase. In addition, LA suppressed interleukin (IL)-12/IL-18 induced IFNγ secretion and cytotoxicity in NK cells. These novel findings suggest that LA may inhibit NK cell function via the cAMP signaling pathway. Published by Elsevier B.V.
Introduction
Multiple sclerosis (MS) is a chronic, inflammatory disorder of the central nervous system (CNS) that is characterized by immune cell infiltration and destruction of oligodendrocytes, the myelin sheath and axons. Though early studies implicate CD4+ myelin-reactive T cells as the cells responsible for initiating the inflammatory response, the actual cellular mediators of tissue injury are becoming more complex. Several reports have recently focused on the potential role of NK cells in MS (Morandi et al., 2008) .
NK cells are large granular cells that express CD16 and/or CD56, but not CD3. They are important components of the innate immune response to invading pathogens, including bacteria, and viruses and tumor cells (French and Yokoyama, 2003; Korbel et al., 2004) . How NK cells contribute to the pathogenesis of MS is still being studied. There is evidence that NK cells can both exacerbate and protect against experimental autoimmune encephalomyelitis (EAE) and may also be pathogenic or protective in MS (Morandi et al., 2008) . For instance, NK cells are implicated in mediating cytotoxicity toward oligodendrocytes as a mechanism for tissue injury in MS (Antel et al., 1998) . Shi et al. reported an IFNγ dependent and disease promoting effect of NK cells in a mouse model of EAE (Shi et al., 2000) . Conversely, a study by Aranami et al. (2006) revealed that NK cells differentially express the CD11c marker, which coincides with disease course of MS. The investigators suggested that CD11c high expressing NK cells are associated with more unstable and severe condition of MS whereas those expressing CD11c low were associated with remission. Similarly, Saraste et al. (2007) 
